共 71 条
[1]
Adachi I(1996)A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer Br J Cancer 73 210-6
[2]
Watanabe T(2005)Adjuvant docetaxel for node-positive breast cancer N Engl J Med 352 2302-13
[3]
Takashima S(2002)Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel J Clin Oncol 20 1456-66
[4]
Narabayashi M(2005)Effects of chemotherapy and hormonal therapy for breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687-717
[5]
Horikoshi N(2001)Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 30 96-102
[6]
Aoyama H(1998)Meeting highlights: international consensus panel on the treatment of primary breast cancer J Natl Cancer Inst 90 1601-8
[7]
Martin M(1988)Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women N Engl J Med 319 1681-2
[8]
Pienkowski T(1998)Polychemotherapy for early breast cancer: an overview of the randomized trials Lancet 352 930-42
[9]
Mackey J(2003)Improved outocomes from adding sequential paclitaxel but not from escalating of doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer J Clin Oncol 21 976-83
[10]
Pawlicki M(2006)Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients; the FNCLCC PACS 01 trial J Clin Oncol 24 5664-71